4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-16-153091
CIK 0001382911operating
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:09 PM ET
Size
8.0 KB
Accession
0001209191-16-153091
Insider Transaction Report
Form 4
Cannell Thomas R
Chief Commercial Officer
Transactions
- Award
Common Stock
2016-11-30$1.67/sh+291$486→ 1,763 total
Footnotes (1)
- [F1]Shares acquired under Issuer's 2013 Employee Stock Purchase Plan.
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 5:09 PM ET
- Size
- 8.0 KB